Levosimendan modulates programmed forms of cell death through K ATP channels and nitric oxide

Journal of Cardiovascular Pharmacology

Volumn 57, Issue 2, 2011, Pages 246-258

  Uberti, Francesca ^a   Caimmi, Philippe P ^a   Molinari, Claudio ^a   Mary, David ^a   Vacca, Giovanni ^a   Grossini, Elena ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

apoptosis; autophagy; levosimendan; NO; potassium channels

Indexed keywords

3 METHYLADENINE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CASPASE INHIBITOR; CYCLOSPORIN A; HYDROGEN PEROXIDE; LEVOSIMENDAN; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL ACTIVATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; HEART MUSCLE CELL; HEART PROTECTION; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL DEATH; CELL LINE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDRAZONES; NITRIC OXIDE; OXIDATIVE STRESS; POTASSIUM CHANNELS; PYRIDAZINES; RATS;

EID: 79951555024     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e318204bb55     Document Type: Article

References (57)

1. Papp Z, Csapo K, Pollessello P, et al. Pharmacological mechanisms contributing to the clinical efficacy of levosimendan. Cardiovasc Drug Rev. 2005;23:71-98. (Pubitemid 40571678)
2. Mebazaa A, Barraud D, Welschbillig S. Randomized clinical trials with levosimendan. Am J Cardiol. 2005;96:74G-79G. (Pubitemid 41338077)
3. Haikala H, Kaivola J, Nissinen E, et al. Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan. J Mol Cell Cardiol. 1995;27:1859-1866.
4. Kopustinskiene DM, Pollesello P, Saris NE. Levosimendan is a mito-chondrial KATP channel opener. Eur J Pharmacol. 2001;428:311-314. (Pubitemid 33016646)
5. Yokoshiki H, Katsube Y, Sunagawa M, et al. The novel calcium sensitizer levosimendan activates the ATP-sensitive K1 channel in rat ventricular cells. J Pharmacol Exp Ther. 1997;283:375-383. (Pubitemid 27438984)
6. Halestrap AP. The regulation of the matrix volume of mammalian mitochondria in vivo and in vitro and its role in the control of mitochondrial metabolism. Biochim Biophys Acta. 1989;973:355-382. (Pubitemid 19073722)
7. Grover GJ, Garlid KD. ATP-sensitive potassium channels: a review of their cardioprotective pharmacology. J Mol Cell Cardiol. 2000;32:677-695. (Pubitemid 30658936)
8. Oldenburg O, Cohen M, Yellon D, et al. Mitochondrial KATP channels: role in cardioprotection. Cardiovasc Res. 2002;55:429-437. (Pubitemid 34874938)
9. Szewczyk A, Marban E. Mitochondria: a new target for K channel openers? Trends Pharmacol Sci. 1999;20:157-161.
10. Ozcan C, Bienengraeber, Dzeja PP, et al. Potassium channel openers protect cardiac mitochondria by attenuating oxidant stress at reoxygena-tion. Am J Physiol Heart Circ Physiol. 2002;282:H531-H539. (Pubitemid 34654976)
11. Maytin M, Colucci W. Cardioprotection: a new paradigm in the acute management of acute heat failure syndromes. Am J Cardiol. 2005;96:26G-31G. (Pubitemid 41338071)
12. Adamopoulos S, Parissis JT, Iliodromitis EK, et al. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure. Am J Cardiol. 2006; 98:102-106. (Pubitemid 43902695)
13. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science. 2000;290:1717-1721. (Pubitemid 32004796)
14. Codogno P, Meijer AJ. Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ. 2005;12:1509-1518. (Pubitemid 41553987)
15. Pattingre S, Tassa A, Qu X, et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell. 2005;122:927-939. (Pubitemid 41345209)
16. Shimizu S, Kanaseki T, Mizushima N, et al. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol. 2004;6:1221-1228. (Pubitemid 39625121)
17. Zeng X, Overmeyer JH, Maltese WA. Functional specificity of the mammalian Beclin-Vps34 PI 3-kinase complex in macroautophagy versus endocytosis and lysosomal enzyme trafficking. J Cell Sci. 2006; 119:259-270. (Pubitemid 43210695)
18. Boya P, Gonzalez-Polo RA, Casares N, et al. Inhibition of macro-autophagy triggers apoptosis. Mol Cell Biol. 2005;25:1025-1040.
19. Hamacher-Brady A, Brady NR, Gottlieb RA. The interplay between pro-death and pro-survival signaling pathways in myocardial ischemia/ reperfusion injury: apoptosis meets autophagy. Cardiovasc Drugs Ther. 2006;20:445-462. (Pubitemid 46150867)
20. Grossini E, Caimmi PP, Platini F, et al. Modulation of programmed forms of cell death by intracoronary levosimendan during regional myocardial ischemia in anesthetized pigs. Cardiovasc Drugs Ther. 2010;24:5-15.
21. Sun HY, Wang NP, Kerendi F, et al. Hypoxic postconditioning reduces cardiomyocyte loss by inhibiting ROS generation and intracellular Ca2+ overload. Am J Physiol Heart Circ Physiol. 2005;288:H1900-H1908. (Pubitemid 40418019)
22. Grossini E, Molinari C, Caimmi PP, et al. Levosimendan induces NO production through p38 MAPK, ERK and Akt in porcine coronary endothelial cells: role for mitochondrial K(ATP) channel. Br J Pharmacol. 2009;156:250-261.
23. Maruyama R, Goto K, Takemura G, et al. Morphological and biochemical characterization of basal and starvation-induced autophagy in isolated adult rat cardiomyocytes. Am J Physiol Heart Circ Physiol. 2008;295: H1599-H1607.
24. Förster K, Paul I, Solenkova N, et al. NECA at reperfusion limits infarction and inhibits formation of the mitochondrial permeability transition pore by activating p70S6 kinase. Basic Res Cardiol. 2006;101: 319-326. (Pubitemid 43923388)
25. Dedkova EN, Blatter LA. Characteristics and function of cardiac mitochondrial nitric oxide synthase. J Physiol. 2009;587:851-872.
26. Razavi HM, Hamilton JA, Feng Q. Modulation of apoptosis by nitric oxide: implications in myocardial ischemia and heart failure. Pharmacol Ther. 2005;106:147-162. (Pubitemid 40613056)
27. Buja LM, Vela D. Cardiomyocyte death and renewal in the normal and diseased heart. Cardiovasc Pathol. 2008;17:349-374.
28. Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science. 2004;305:626-629. (Pubitemid 39006738)
29. Thorburn A. Death receptor-induced cell killing. Cell Signal. 2004;16: 139-144. (Pubitemid 37431163)
30. Tsujimoto Y. Cell death regulation by the Bcl-2 protein family in the mitochondria. J Cell Physiol. 2003;195:158-167. (Pubitemid 36384290)
31. Hengartner MO. The biochemistry of apoptosis. Nature. 2000;407: 770-776.
32. Zou H, Henzel WJ, Liu X, et al. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell. 1997;90:405-413. (Pubitemid 27347231)
33. Muzio M, Chinnaiyan AM, Kischkel FC, et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/ APO-1) death-inducing signaling complex. Cell. 1996;85:817-827. (Pubitemid 26193033)
34. Gu Q, Wang JD, Xia HH, et al. Activation of the caspase-8/Bid and Bax pathways in aspirin-induced apoptosis in gastric cancer. Carcinogenesis. 2005;26:541-546. (Pubitemid 41214142)
35. Kundu M, Thompson CB. Autophagy: basic principles and relevance to disease. Annu Rev Pathol Mech Dis. 2008;3:427-455. (Pubitemid 351488288)
36. Yasuoka C, Ihara Y, Ikeda S, et al. Antiapoptotic activity of Akt is downregulated by Ca2+ in myocardiac H9c2 cells. Evidence of Ca(2+)-dependent regulation of protein phosphatase 2Ac. J Biol Chem. 2004;279: 51182-51192. (Pubitemid 40017861)
37. Murata H, Ihara Y, Nakamura H, et al. Glutaredoxin exerts an antiapoptotic effect by regulating the redox state of Akt. J Biol Chem. 2003;278:50226-50233. (Pubitemid 37548863)
38. Han H, Long H, Wang H, et al. Progressive apoptotic cell death triggered by transient oxidative insult in H9c2 rat ventricular cells: a novel pattern of apoptosis and the mechanisms. Am J Physiol Heart Circ Physiol. 2004; 286:H2169-H2182. (Pubitemid 38685231)
39. Pollesello P, Papp Z. The cardioprotective effects of levosimendan: preclinical and clinical evidence. J Cardiovasc Pharmacol. 2007;50: 257-263. (Pubitemid 47428972)
40. Kersten JR, Montgomery MW, Pagel PS, et al. Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels. Anesth Analg. 2000;90:5-11. (Pubitemid 30022959)
41. Borutaite V, Jekabsone A, Morkuniene R, et al. Inhibition of mitochondrial permeability transition prevents mitochondrial dysfunction, cytochrome c release and apoptosis induced by heart ischemia. J Mol Cell Cardiol. 2003;35:357-366. (Pubitemid 36411697)
42. Pestana CR, Silva CH, Uyemura SA, et al. Impact of adenosine nucleotide translocase (ANT) proline isomerization on Ca2+-induced cysteine relative mobility/mitochondrial permeability transition pore. J Bioenerg Biomembr. 2010;42:329-335.
43. Weiland U, Haendeler J, Ihling C, et al. Inhibition of endogenous nitric oxide synthase potentiates ischemia-reperfusion-induced myocardial apoptosis via a caspase-3 dependent pathway. Cardiovasc Res. 2000; 45:671-678. (Pubitemid 30047133)
44. Bell RM, Yellon DM. Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway. J Am Coll Cardiol. 2003;41: 508-515. (Pubitemid 36164511)
45. Das B, Sarkar C. Pharmacological preconditioning by levosimendan is mediated by inducible nitric oxide synthase and mitochondrial KATP channel activation in the in vivo anesthetized rabbit heart model. Vascul Pharmacol. 2007;47:248-256. (Pubitemid 47470049)
46. Cuong DV, Kim N, Youm JB, et al.Nitric oxide-cGMP-protein kinase G signaling pathway induces anoxic preconditioning through activation of ATP-sensitive K+ channels in rat hearts. Am J Physiol Heart Circ Physiol. 2006;290:H1808-H 1817.
47. Han J, Kim HN, Joo H, et al. ATP-sensitive K(+) channel activation by nitric oxide and protein kinase G in rabbit ventricular myocytes. Am J Physiol Heart Circ Physiol. 2002;283:H1545-H1554.
48. Sasaki N, Sato T, Ohler A, et al. Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. Circulation. 2000;101: 439-445. (Pubitemid 30067402)
49. Shinbo A, Iijima T. Potentiation by nitric oxide of the ATP-sensitive K+ current induced by K+ channel openers in guinea-pig ventricular cells. Br J Pharmacol. 1997;120:1568-1574. (Pubitemid 27192450)
50. Borutaite V, Morkuniene R, Arandarcikaite O, et al. Nitric oxide protects the heart from ischemia-induced apoptosis and mitochondrial damage via protein kinase G mediated blockage of permeability transition and cytochrome c release. J Biomed Sci. 2009;16:70.
51. Nakano A, Liu GS, Heusch G, et al. Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. J Mol Cell Cardiol. 2000;32:1159-1167.
52. Brunner F, Maier R, Andrew P, et al. Attenuation of myocardial ischemia/reperfusion injury in mice with myocyte-specific overexpres-sion of endothelial nitric oxide synthase. Cardiovasc Res. 2003;57: 55-62. (Pubitemid 36009436)
53. Rakhit RD, Mojet MH, Marber MS, et al. Mitochondria as targets for nitric oxide-induced protection during simulated ischemia and reoxygenation in isolated neonatal cardiomyocytes. Circulation. 2001;103:2617-2623. (Pubitemid 32521974)
54. Ravikumar B, Vacher C, Berger Z, et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet. 2004;36:585-595. (Pubitemid 38715985)
55. Beugnet A, Tee AR, Taylor PM, et al. Regulation of targets of mTOR (mammalian target of rapamycin) signaling by intracellular amino acid availability. Biochem J. 2003;372:555-566. (Pubitemid 36723901)
56. Khan S, Salloum F, Das A, et al. Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes. J Mol Cell Cardiol. 2006;41:256-264. (Pubitemid 44080210)
57. Rabkin SW, Klassen SS. Nitric oxide differentially regulates the gene expression of caspase genes but not some autophagic genes. Nitric Oxide. 2007;16:339-347. (Pubitemid 46541669)